Results 101 to 110 of about 1,213 (179)
Hemolytic Disease of the Fetus and Newborn Caused by Maternal Alloanti-Fy(a)
Hemolytic disease of the fetus and newborn (HDFN) is commonly attributed to maternal antibodies against fetal red blood cell antigens, with anti-D being the most frequent cause. However, other antibodies, such as anti-Fya from the Duffy blood group system, can also lead to HDFN, although they are less commonly reported.
Robins, Rowena D.L. +3 more
openaire +2 more sources
ABSTRACT Two neonates with metallo‐β‐lactamase‐producing Acinetobacter baumannii meningitis, resistant to every tested alternative, received ceftriaxone–sulbactam–disodium EDTA plus intravenous colistin, which, to our knowledge, represents the first reported neonatal use of this combinations. Cultures were sterilized by day 7; both survived with normal
Naini Puri +5 more
wiley +1 more source
Hemolytic Disease of the Fetus and Newborn in an Integrated Health Care System
AbstractHemolytic disease of the fetus and newborn (HDFN) is associated with significant infant morbidity and mortality. Characteristics of pregnancies impacted by HDFN are not well understood. Therefore, this study examines maternal and infant characteristics based on HDFN status in a large, integrated health care system in the United States.This was ...
Michael J. Fassett +12 more
openaire +3 more sources
Hypertrophic Cardiomyopathy With Superimposed Pre‐Eclampsia in a Grand Multiparous Woman
ABSTRACT This case report highlights the importance of clinical vigilance, the role of echocardiography, and the benefits of guideline‐directed multidisciplinary management of pregnant women with HCM in resource‐limited settings. Advocating for comprehensive multidisciplinary care models is essential in optimizing maternal and fetal health outcomes ...
Prince Yaw Boahene +7 more
wiley +1 more source
Perinatal outcomes in normotensive versus hypertensive HELLP syndrome
Abstract Objective To compare maternal and neonatal outcomes between women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome with and without associated hypertension. Methods This was a retrospective cohort study at a tertiary university‐affiliated medical center including all singleton HELLP cases >24 weeks gestation (January ...
Matan Anteby +4 more
wiley +1 more source
A review of evidence on non-invasive prenatal diagnosis (NIPD) : tests for fetal RHD genotype [PDF]
This report concentrates on three main areas. First and foremost, we set the background context for RhD NIPD in prenatal care. While the methodology chapter describes how the literature review was carried out and how additional information was collected,
Clay, Diane +5 more
core
Conclusion: PS, VCAM-1, and VE-Cad provide experimental evidence for prenatal screening, diagnosis, early prevention and treatment of ABO-HDFN.
Weichun Tang +3 more
doaj +1 more source
Correlation between maternal parity and ABO hemolytic disease of the fetus and newborn
[Objective] To investigate the correlation between maternal parity and ABO hemolytic disease of the fetus and newborn (ABO-HDFN). [Methods] A total of 244 neonates diagnosed with ABO-HDFN who were admitted to the neonatology department of of our hospital
YANG Li, LIU Wei, ZHAO Yuan, LI Daihong
doaj +1 more source
Schematic illustration of the molecular mechanism by which CD8a‐NVE@KRN2 targets the NFAT5/PD‐1 axis in CD8+ T cells, inducing pyroptosis in cancer cells and reprogramming TAM glycolytic metabolism to enhance the efficacy of immunotherapy in CC. Note: Created in BioRender.
Xinxin Zhang +9 more
wiley +1 more source
Hemolytic disease of the newborn (HDN) refers to the destruction of the fetal and newborn red cells by maternal red cell antibodies specific for paternally inherited antigens on fetal red cells or erythroid precursors.[1] ABO-incompatibility is the most ...
Rakeshkumar Shah, Ajeemsha Anvarsha
doaj +1 more source

